LifeVantage
Stock
Stock
Ticker: LFVN
LFVN
Price
Price
CHART BY
Frequently asked questions
What is LifeVantage's market capitalization?
The market capitalization of LifeVantage is $60.62M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is LifeVantage's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for LifeVantage is 22.19. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for LifeVantage?
LifeVantage's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.215. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for LifeVantage's stock?
Currently, 2 analysts cover LifeVantage's stock, with a consensus target price of $6.50. Analyst ratings provide insights into the stock's expected performance.
What is LifeVantage's revenue over the trailing twelve months?
Over the trailing twelve months, LifeVantage reported a revenue of $172.14M.
Is LifeVantage paying dividends?
Yes, LifeVantage is paying dividends. The next payment is scheduled for 15.12.2026, with an expected amount of .
What is the EBITDA for LifeVantage?
LifeVantage's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $6.59M. EBITDA measures the company's overall financial performance.
What is the free cash flow of LifeVantage?
LifeVantage has a free cash flow of $8.71M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does LifeVantage have, and what sector and industry does it belong to?
LifeVantage employs approximately 223 people. It operates in the Health Care sector, specifically within the Other Pharmaceuticals industry.
What is the free float of LifeVantage's shares?
The free float of LifeVantage is 10.30M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $60.62M
- EPS (TTM)
- $0.215
- Free Float
- 10.30M
- P/E ratio (TTM)
- 22.19
- Revenue (TTM)
- $172.14M
- EBITDA (TTM)
- $6.59M
- Free Cashflow (TTM)
- $8.71M
Pricing
- 1D span
- $4.814$4.88
- 52W span
- $3.91$11.55
Analyst Ratings
The price target is $6.50 and the stock is covered by 2 analysts.
Buy
1
Hold
1
Sell
0
Information
LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. It operates through the Americas, Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.
- Employees
- 223
- Industries
- Other Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- LFVN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet